kidney; cytoskeleton; motor; disease; actin MYOSIN I␤ is a member of the myosin superfamily that contains at least 15 distinct classes (33) . All myosins contain an actin and ATP binding site in their globular head or motor region, while the myosin tail regions are quite diverse. Many myosin class members have been identified by molecular techniques in both lower and higher eukaryotes (23, 33, 40) . In addition, multiple studies have identified multiple myosins in the same tissue and/or cells, suggesting that these molecular motors may coordinate their respective or redundant roles in cells. The myosin I class members have three functional domains (3, 12) . At the amino terminus is a 70-to 80-kDa region that contains the ATP and actin binding site. The ␣-helical neck region contains one to six IQ (isoleucine-glutamine) motifs that interact with light chains that are calmodulin in vertebrates. The carboxy end domain, ϳ20 kDa, is enriched in basic amino acids that interact with acidic phospholipids. Numerous studies have proposed a role for myosin I's in cell motility, endocytosis, secretion, contractile function, and Golgi vesicle trafficking and in linking the actin bundles of microvilli to the plasma membrane. All these activities involve an interaction with membrane and actin filaments, a dual property for which myosin I's are well equipped.
There are at least four distinct classes of myosin I that are widespread in mammalian tissues, including kidney (12, 23, 33, 40) . The four classes have been designated as I␣, I␤, IC, and I␥, whereas in rat they are termed myr1, myr2, myr3, and myr4 (3, 33) . The human cDNA for myosin I␤ also has been characterized and is called Myo1c (33) . Myosin I␤ was the first mammalian myosin I purified (2) . Western blots and immunofluorescence have shown this isoform to be widely distributed, being found in all rat tissues examined and present in active motile regions of cells, i.e., lamellipodia and ruffles (1, 12, 30, 36, 40) . In addition, a punctate cytoplasmic pattern is observed in both cell and tissue immunolabeling. Recent studies suggest that myosin I may be involved in the regulation of mechanochemical transduction channels in the apical region of hair cell stereocilia in the inner ear (16, 18) . We have previously localized myosin I␤ to microvilli in a proximal tubule cell line, LLCPK, and have shown that it was also present in the brush border (BB) of proximal tubules (37) .
Proximal tubule cells (PTC) have a specialized apical membrane that mediates the selective and efficient reabsorption of ions, water, and macromolecules from the glomerular filtrate (6, 24) . Reabsorption requires microvilli and delivery of ion channels, receptors, and regulatory molecules to their correct destination, thus enabling the establishment and maintenance of surface membrane polarity. These processes depend, in part, on actin-surface membrane interactions and vesicular transport, both processes in which myosin I has been implicated. The apical region of the PTC is a very dynamic region composed of the terminal web and microvilli, each containing a high concentration of actin and lacking microtubules. The pit area at the base of the microvilli is a site of active endocytosis, and myosin I␤ has been identified in an endosome fraction from this region (17) . Importantly, membrane channels and other proteins and lipids are continuously deliv-ered to the plasma membrane of all kidney tubules to replenish and maintain a cellular environment capable of executing urinary function. Ischemia in vivo or ATP depletion in vitro severely alters PTC actin cytoskeleton and inhibits ATP-dependent vectorial transport of organelles (4, 13, 24, 35) . Data from numerous labs have documented that ischemia-reperfusion results in cellular changes throughout the kidney, including proximal and distal tubules (4, 13-15, 19, 21, 24, 25, 29) . The alterations combined lead to cellular and organ-level dysfunction. Return to the normal physiological state requires cellular events involving both the actin cytoskeleton and vectorial transport.
We previously documented the changes to myosin I␤ in an established, reversible in vitro ischemic model, LLCPK ATP depleted/repleted (37) . In that study, myosin I␤ was shown for the first time to be present in microvilli, to undergo apparent cross-linking with actin after ATP depletion, and to return to a normal distribution after ATP repletion. Myosin I␤ also was observed in the cytoplasm and at the lateral cell borders of cells. If this unconventional myosin participates in the structural stability of the microvilli, its presence in the BB should coincide with the return of the BB after ischemia. However, a return after BB formation would suggest that it is participating in some other cellular function in these cells. Consequently, the objective of these studies was to analyze the distribution of myosin I␤ in the rat kidney under normal physiological conditions, during ischemia, and after reperfusion following ischemia. Interestingly, we found myosin I␤ in many tubule segments. We found that myosin I␤ is indeed concentrated in the BB of PTCs but also is present in a punctate pattern in the cytoplasm. Ischemia dramatically altered the BB morphology and resulted in a loss of myosin I␤ from the BB and an apparent dissociation from F-actin. However, Western blot analysis of both kidney and urine samples from the injury and recovery process shows minimal loss of myosin I␤. This finding suggests that the changes we observed by immunofluorescence are the result of dramatic redistribution and/or reorganization of myosin I␤ in the proximal tubule. Fifteen minutes of ischemia followed by 2 h of recovery resulted in structurally normal microvilli. However, myosin I␤, detected by immunofluorescence, had not returned to its predominant BB location in the proximal tubules but was found predominantly in the cytoplasm. Even after 24 h of recovery we observed more cytoplasmic and less BB staining of myosin I␤. These studies suggest that myosin I␤ does not play a structural role in the early stages of microvilli rebuilding. In fact, its presence in all kidney tubules suggests a more ubiquitous role for myosin I␤, possibly in vesicular transport or other cellular functions requiring membrane-actin interactions.
MATERIALS AND METHODS
Antibodies. The primary antibodies against myosin I␤ have been characterized and used in multiple studies (1, 9, 36, 37) . Briefly, highly purified adrenal myosin I␤ was the antigen used, and the resulting mouse monoclonal antibodies react with a specific band in the rat kidney (Fig. 1 ). M2 and M3 have been mapped to a tail region specific for this myosin I isoform, and M4 and M5 have been mapped to a head domain region containing the actin and ATP binding sites (36, 37 Northern blot analysis. At the specified time of ischemia and/or reperfusion, the kidneys were briefly (Ͻ20 s) perfused with PBS, and the cortex, medulla, and papilla were separated and rapidly frozen in liquid nitrogen. Frozen tissue was homogenized with the Bio-Pulverizer (Biospec Products, Bartlesville, OK) in liquid nitrogen, and powdered tissue was then poured into a tube containing the TRI reagent (Molecular Research Center, Cincinnati, OH). Total RNA was prepared according to the manufacturer's protocol. For Northern blots, total RNA was electrophoresed in 1% agarose gels containing 1.85% formaldehyde. Equal loading was assessed by optical density reading of samples before loading and by analysis of 28S RNA bands after the gel run. The RNA was 4) , medulla (lanes 2 and 5), and BBM (lanes 3 and 6) were loaded. Lanes 1-3 were stained with Gel Code Silver Snap stain. Lanes 4-6 were Western blotted for myosin I␤ and actin. M2 and M5 monoclonal antibodies against myosin I␤ were used. Note the enrichment of the actin in the BBM sample. B and C: BBM, cortex, or medulla samples were extracted in Ͻ500 l with 1% Triton X-100 (TX-100) plus (in mM) 250 sucrose, 6 PIPES, 2.5 HEPES, 0.2 EGTA, and 0.2 MgCl2, pH 6.9, on ice for 10 min. The solubilized proteins were separated from the insoluble by centrifugation at 48,000 g for 30 min. Equal amounts of cortex and medulla protein were extracted, and pellets were resuspended to volume. Equal volumes were then loaded on the gel. The BBM sample used for extraction contained approximately one-sixth the amount of protein. S, supernatant; P, pellet. transferred onto nylon membranes using the Schleicher and Schuell Turbo blotter (Keene, NH). The membranes were prehybridized for 15 min and hybridized for 2 h at 65°C using Rapid-hyb buffer (Amersham). The probe was a 700-bp myosin I␤ cDNA tail fragment labeled using the Rediprime DNA labeling system (Amersham). The filter was washed twice with 2ϫ sodium saline citrate (SSC)-0.1% SDS at room temperature for 5 min each time, once for 15 min with 0.5ϫ SSC-0.1% SDS at 65°C, and once for 15 min with 0.2ϫ SSC-0.1% SDS at 65°C. Analysis and quantitation were conducted with a Molecular Dynamics PhosphorImager. All analyses compared the clamped kidney with the contralateral unclamped kidney. RNA levels of the paired kidneys were normalized using a glyceraldehyde-3-phosphate dehydrogenase probe. Data are presented as means Ϯ SE. Statistical analysis was performed with the ANOVA and Tukey's honestly significant difference analysis, and a P value Ͻ0.05 was considered statistically significant.
Immunofluorescence of rat kidney sections. Rat kidneys were perfusion-fixed according to the procedure of Maunsbach and Afzelius (22) . Briefly, the animals were anesthetized with an intraperitoneal injection of ketamine-xylazine and atropine. The abdominal aorta and viscera were exposed via a midline incision, and sutures were placed superior and inferior to the renal blood vessels to confine the perfusate flow primarily to the kidneys. A catheter was secured in the abdominal aorta in the retrograde direction for delivery of a prefixation rinse of 20 ml of warmed and filtered 0.85% saline containing 3 U/ml of heparin, followed by the fixation solution containing filtered 2% paraformaldehyde in PBS, pH 7.4, warmed to 37°C. The kidneys were perfusionfixed for 5 min at a flow rate of 50 ml/min at an average pressure of 140 mmHg. After perfusion fixation, the kidneys were removed from the animal, the capsule and perirenal fat were dissected away, and the tissue was trimmed for immersion fixation at 4°C. Larger blocks were sectioned on a Vibratome for immunofluorescence, and smaller blocks ϳ1 mm 3 were processed for electron microscopy (EM). Sections 50-100 m thick were obtained with the use of the Vibratome, and the sections were placed in 0.20% paraformaldehyde until labeled. For immunolabeling, the sections were rinsed with PBS and placed into 1% SDS or 1% Triton X-100 for 5 min (5). After detergent treatment, the tissue sections were rinsed in PBS and placed in PBS-50 mM EGTA containing the primary antibody (10 g/ml). Incubation was at room temperature overnight, with gentle agitation. The sections were extensively (minimum 6ϫ 30 min) washed with PBS at room temperature, followed by an overnight incubation with the secondary antibody (goat anti-mouse IgG conjugated to Cy5, Jackson ImmunoResearch, or Alexa 568, Molecular Probes, Eugene, OR) 5 g/ml in 3% BSA in PBS. F-actin was labeled by including Alexa 488 or Oregon Green phalloidin (Molecular Probes) diluted 1:200 with the secondary antibody. FITC-labeled lectins were used at a concentration of 10 g/ml. The sections were again rinsed with PBS and mounted on coverslips using ProLong (Molecular Probes). Immunofluorescence controls included omission of the primary antibody, use of multiple secondary antibodies that gave the same pattern for myosin I␤, and use of several additional irrelevant monoclonal antibodies at the same concentration as the myosin I␤ antibodies. Omission of both the primary and irrelevant antibodies resulted in negligible staining.
A Bio-Rad (Hercules, CA) MRC 1024 laser scanning confocal microscope was used to acquire images. Focal sections were obtained in 0.5-or 1-m steps with Kalman averaging. Each black-and-white image presented is a single focal plane unless stated otherwise. Three-dimensional (3-D) reconstruction of a series of images was performed with the use of MetaMorph's (Universal Imaging, West Chester, PA) stack 3-D reconstruction function. All digital images were imported into MetaMorph, and image planes were selected and transferred to PowerPoint for labeling and scaling. Color encoding was performed in MetaMorph by assigning the red and blue channels to the myosin I␤ signal and the green channel to the F-actin signal. The resulting images show myosin I␤ in purple and F-actin in green, and colocalization is shown as white.
Induction of renal ischemia and urine collection. In Sprague-Dawley rats utilized for microscopy and RNA isolation, renal ischemia was induced by clamping of the renal pedicle of the left kidney, with the contralateral kidney serving as the paired control (26) . The rats used for urine and total protein changes were subjected to a bilateral renal clamp. We found no difference in the morphological changes and distribution of myosin I␤ and F-actin between the 15-min unilateral and bilateral clamp models. Rats were acclimated to metabolic cages for 2-3 days before the bilateral clamp was performed. Urine was collected 24 h before surgery and after 2 and 24 h of reperfusion following the 15-min clamp. Urine volume was measured and monitored using Bayer Multistix for urinalysis. The urine was centrifuged for 15 min at 17,000 g, and the supernatant was assayed. Kidneys were removed at 2 or 24 h after reperfusion and separated into cortex and medulla (including papilla and pelvis). Tissue was solubilized with SDS. These protein and urine samples were used for semiquantitative analysis of myosin I␤ changes after the ischemic injury (see Fig. 4 ).
Other methods. Tissue for EM analysis was obtained as described in Immunofluorescence of rat kidney sections, with the tissue blocks processed according to the procedure of Maunsbach and Afzelius (22) . Briefly, blocks were rinsed in PBS twice for 30 min to remove fixative, postfixed in 1% osmium tetraoxide for 1 h at 4°C, rinsed in PBS twice for 30 min, dehydrated through an ethanol series, and embedded in Spurrs resin. Thick sections (0.5 m) were cut on an RMC (Research Manufacturing Company, Tucson, AZ) microtome and stained with 1% toluidine blue for light microscopy. Thin sections (90-120 nm) were cut and stained with uranyl acetate followed by lead citrate and were viewed with a Philips CM 10 electron microscope. Protein concentration was determined using Pierce's BCA Protein Assay Reagent or Bio-Rad's Protein Assay.
RESULTS
Myosin I␤ is widely distributed in the rat kidney. We previously showed that myosin I␤ was present in the microvilli of LLCPK1 PTCs and that its distribution was altered by ATP depletion (37) . The primary objective in these studies was to determine the distribution of myosin I␤ in the rat kidney under normal physiological conditions, after an ischemic insult, and during reperfusion. Figure 1A shows the specificity of the antibodies used in these studies. Western blot analysis of rat kidney cortex, medulla, and BB membranes (BBM) is shown.
Most myosin I␤ in rat kidneys is Triton X-100 insoluble in contrast to that in LLCPK cells, which under control conditions is close to 90% soluble (37) . Figure 1 , B and C, shows the results from a Triton X-100 extraction of BBM, cortex, and medulla. After extraction on ice, the sample was centrifuged, and the supernatant and pellet were analyzed by silver stain (Fig. 1B) and Western blot (Fig. 1C) for myosin I␤. Note that the majority of myosin I␤ is present in the F-actin-containing pellet in all samples. Over 90% of myosin I␤ was found in the supernatant when ATP was added before centrifugation (data not shown). This finding agrees with our data from the in vitro ATP-depletion model. We observed no significant change in the Triton X-100 solubility of myosin I␤ after ischemia or reperfusion in rat kidney (data not shown). This is likely due to the highly organized and developed cytoskeleton in vivo compared with the in vitro model.
Immunofluorescence images in Figs. 2 and 3 show that myosin I␤ is widely distributed in the rat kidney.
In Fig. 2 , three rat kidney Vibratome sections doublelabeled for myosin I␤ (A, C, and E) and F-actin (B, D, and F) are shown. Figure 2 , A and B, represent single planes, while Fig. 2 , C-F, are reconstructions from multiple confocal planes. Note the prominent myosin I␤ BB labeling in the proximal tubules. The intense labeling of F-actin with phalloidin easily identifies proximal tubules. We often observed a zone of reduced myosin I␤ labeling under the BB that may correspond to the terminal web. There is also distinct cytoplasmic myosin I␤ staining that appears rather punctate in many of the tubules. In Fig. 3 , sections were doublelabeled for myosin I␤ (A and C) and peanut lectin (B and D) to address the presence of myosin I␤ in nonPTCs. Peanut lectin labels primarily the intercalated cells in the rat kidney, though some staining has been observed in the inner medulla (7, 20) . Myosin I␤ is clearly present throughout the cytoplasm of collecting duct cells and is often concentrated near the apical surface of these cells. This distribution, along with its presence in the BB of PTCs, is consistent with a role for myosin I␤ that involves regulating the dynamic actin network found near the plasma membrane in these cells (6) .
Changes induced by ischemia. Ischemia has been shown to alter many cellular proteins and functions and has been most extensively studied in the PTCs (4, 24, 35). Our objective in these studies was to assess changes to myosin I␤ caused by ischemia and to determine when myosin I␤ returns to normal. We chose to use a 15-min ischemic clamp because structural alterations to the proximal tubules have been documented to follow this period of ischemia (26, 38, 39) . Furthermore, this brief ischemic injury will result in less cell death and enable a quicker return to normal cell structure and function.
The first analysis addressed whether ischemiareperfusion altered levels of myosin I␤ mRNA. Quantitation of Northern blots, shown in Fig. 4A , showed changes to myosin I␤ expression in both cortex and medulla after a 15-min clamp and different times of recovery. Note that after 2 and 4 h of reperfusion, there was an increase in expression of myosin I␤ mRNA in both the cortex and medulla. After 24 h there was a significant decrease in myosin I␤ expression in the medulla that did not return to normal levels till after 3 days of reperfusion. Myosin I␤ mRNA in the cortex returned to normal levels within 3 days of reperfusion. These data suggest that myosin I␤ mRNA expression is regulated differently in cortex and medullary cells and that its recovery from an ischemic injury occurs more slowly in the medullary cells. An increase in mRNA expression could be caused by the need to replace myosin I␤ that has been lost. Western blot analysis of kidney proteins (Fig. 4B ) was conducted to determine whether myosin I␤ protein levels change after an ischemic injury. Quantitation using the UN-SCAN-IT program (Silk Scientific, Orem, Utah) on scanned blots showed that changes between control and recovery time points varied Ͻ10%. In addition, urine was col- lected and analyzed for its protein content to further evaluate myosin I␤ release. Figure 4C shows the changes in urine protein before and after the ischemic clamp. Note that the urine output (ml/h) is similar under all conditions. To evaluate the urine protein content of the control and 15-min ischemia-24-h reperfusion collections, they were concentrated fivefold. The 15-min ischemia-2-h reperfusion sample was not concentrated. The most notable difference besides the increase in albumin after ischemia was the minor increase in the release of myosin I␤ and actin at the 15-min ischemia-2-h reperfusion collection. Figure 5 shows two rat kidney sections double-labeled for myosin I␤ (A and C) and F-actin (B and D) after 15 min of ischemia. Note the presence of myosin I␤ closer to the apical surface and its presence in cellular blebs (Fig. 5C, arrows) . These alterations were observed in tubules containing distinct F-actin labeling, i.e., proximal tubules, and also in those without distinct F-actin labeling, i.e., nonproximal tubules (Fig.  5A, star) . The changes in location of myosin I␤ are not restricted to proximal tubules and suggest that recovery will require reorganization and retargeting of this protein.
Recovery from ischemia: Does myosin I␤ participate in rebuilding the microvilli?
Having established that myosin I␤ undergoes dramatic changes with ischemia, our next objective was to establish the structural relationship between the reappearance of microvilli and the return of myosin I␤ to the BB. Figure 6 shows the overall cell structure of primarily proximal tubules at both the light and EM level. While there are clearly some areas lacking complete microvilli that can be found after only 2 h of reperfusion (Fig. 6F, arrow) , the majority of the proximal tubules appear to have reformed normal BB with microvilli. Figure 7 highlights the major observations reported for myosin I␤ under control (A) and ischemic (B) conditions and shows the location of myosin I␤ after 15 min of ischemia and 2 (C-F) or 24 h (H and I) of reperfusion. Color images present myosin I␤ in purple and F-actin in green. Colocalization between myosin I␤ and F-actin is indicated as white. Note the prominent BB labeling for both F-actin and myosin I␤ in the control state (Fig. 7A) , where significant white is indicated, and the dramatic disruption to both myosin I␤ and F-actin after ischemia (Fig. 7B) . With 2 h of reperfusion, a modest increase in myosin I␤ mRNA was found (Fig. 4A) with a similar decrease in myosin I␤ protein occurring (Fig. 4B) , and it also was found in the urine (Fig. 4C) . Immunolocalization showed a more dramatic decrease in myosin I␤ staining (Fig. 7, C , E, and F) after 2 h of reperfusion. Although the magnitude of the myosin I␤ decrease was variable, there was a significant reorganization of this protein after ischemia and reperfusion (compare the color image of the control in Fig. 7A with the 2-h recovery state in Fig.  7F ). This was most evident by the reduced staining of the BB for myosin I␤. In addition, the intensity of myosin I␤ labeling was often increased in nonproximal tubular cells at 2 h. These results suggest that myosin I␤ does not participate in the early rebuilding of the microvilli that occurs after reperfusion. By 24 h of reperfusion (Fig. 7, G-I) there were clearly regions of proximal tubules that had myosin I␤ in the BB (Fig.  7H, arrows) , although there was still a higher percentage of cytoplasmic labeling than observed in the normal physiological state, and many proximal tubules had little myosin I␤ in the BB (Fig. H, triangles) . In addition, we often observed an increase in myosin I␤ staining in nonproximal tubules at 24 h of recovery. Interestingly, myosin I␤ was also found in the urine from the 2-to 24-h reperfusion collection. The results combined suggest that a dramatic cytoskeletal and membrane reorganization of kidney cells has taken place, after 15-min clamp, that does not cause any significant release of protein but requires the cells to retarget and reorganize multiple cellular components, one of which is myosin I␤. Normal proximal tubule staining for myosin I␤ returned by 3 days of reperfusion (data not shown). To obtain a better understanding of myosin I␤ changes in other tubule segments, changes to specific tubular markers during ischemiareperfusion must be followed. These studies, along with studies aimed at better defining the recovery of myosin I␤ in the PTC, are needed to provide a clearer picture of the role of myosin I␤ in kidney tubule function and recovery from ischemia.
DISCUSSION
Ischemia triggers many cellular alterations along the nephron (4, 24, 35, 39) . Reduced blood flow results in low cellular ATP levels, effectively inhibiting many Fig. 4 . Ischemia causes minor alterations to kidney myosin I␤ mRNA and protein levels. A: Northern analysis of myosin I␤ mRNA levels in both cortex and medulla is presented at selected time points of ischemia-reperfusion. All analyses compared the clamped kidney with the contralateral unclamped kidney. For each time point, a minimum of 3 samples was analyzed. Data are presented as means Ϯ SE. Cortex and medulla values were combined to perform statistical analysis using ANOVA and the Tukey's honestly significant difference test. The variable tested was recovery time. *Significant differences (P Ͻ 0.05) were found between 2 and 4 h of recovery compared with the 24-h recovery time point. B: a Gel-Code Blue-stained gel and Western blot of 2 identical gels that contained kidney cortex and medulla samples under control conditions, after 15-min ischemia and 2-h recovery (15-2 h), or after 15-min ischemia and 24-h recovery (15-24 h). Total protein (50 g) was loaded in each lane. The gel for Western blotting was cut and probed for myosin I␤ or actin (A), and their respective bands are shown below the Gel-Code Bluestained gel. C: a Gel-Code Blue-stained gel and Western blot of rat urine samples (lanes 1-8) under control (before clamping), after 15-min ischemia and 2-h recovery (15-2 h), or after 15-min ischemia and 24-h recovery (15-24 h). Results from identical gels blotted for myosin I␤ and actin are presented below the stained gel. The control and 15-24 h urine samples were concentrated 5-fold because of their low protein levels. Concentrated urine (5 l) was loaded for the control and 15-24 h samples, and 5 l of collected urine was loaded for the 15-2 h collection. ATP-dependent processes such as phosphorylation, ion regulation, and vesicle trafficking. These alterations contribute to the cell injury observed and lead to tubule and kidney dysfunction. The best-studied ischemic changes occur in proximal tubules, where the apical cytoskeleton undergoes dramatic rearrangement after cessation of blood flow in vivo. Actin, the major protein component of the microvilli, is redistributed in the apical cytoplasm. Its regulation and associated proteins, including ezrin and actin-depolymerizing factor (ADF), are also altered under ischemic conditions (10, 11, 31) . It has become increasingly apparent that ischemia disrupts the normal cellular morphology and physiology of the distal segments of the nephron as well (14, 15, 19, 21, 29) . Return to the normal physiological state requires retargeting of misdirected cellular components and rebuilding of the cytoskeleton.
Myosin I␤ is an actin-activated ATPase with both actin and membrane binding domains (3) . It has three calmodulin light chain binding domains that bind calmodulin strongest in the absence of calcium. Its widespread distribution argues for involvement in a fundamental cell process shared by multiple cell types. In these studies, we analyzed its tubular distribution and addressed its potential structural role in PTC microvilli. It has previously been suggested that myosin I tethers actin to the plasma membrane of the microvillus (27) . Under control conditions, myosin I␤ was found to be ϳ90% Triton insoluble, probably due to its interaction with F-actin. Immunofluorescence labeling of myosin I␤ and F-actin in normal kidney tissue sections showed extensive colocalization of these two proteins in the BBM. There is strikingly no colocalization of myosin I␤ with actin in the stress fibers of these cells. There appears to be a zone of minimal myosin I␤ labeling beneath the BB, which may correspond to the proximal tubule terminal web region. This zone is often followed by a punctate distribution of myosin I␤ in the cytoplasm. The myosin just beneath the BB may be associated with vesicles that are to be transported along actin filaments to the microvillar membrane. Multiple studies have implicated myosin I's as playing a role in endocytosis and intracellular trafficking (23, 33, 40) . Movement into and throughout the BB region, a region lacking microtubules, may utilize an actinbased motor such as myosin I␤. Alternatively, myosin I␤ in the subapical region could be simply waiting for transport to the BB via another myosin motor. Distinguishing whether this myosin is actively involved in transport to the BB or a non-transport function would be aided by a better understanding of what this myosin interacts with and how these interactions are regulated. Interactions between multiple myosin I␤ proteins have been suggested as a prerequisite for this motor to perform work, and the subapical punctate distribution may represent a small cluster of myosin I␤ molecules (28) . It is widely accepted that the actin cytoskeleton plays a role in the regulation of multiple channels; thus it is possible that myosin I actin-based motors contribute to these regulatory processes (8, 32, 34, 38) . Myosin I's may also help shuttle membrane vesicles containing channels to and from the plasma membrane and/or may affect the dynamics of the actin cytoskeleton, thus indirectly contributing to channel regulation.
Under normal physiological conditions, myosin I␤ and actin are concentrated in the BB of the proximal tubule. With ischemic injury, the actin cytoskeleton is disrupted, microvilli shorten and fuse, ATP levels fall, and intracellular calcium levels rise. Low levels of ATP favor formation of a rigor complex between myosin and actin. Interestingly, after 15 min of ischemia, myosin I␤ is observed in cellular blebs in the proximal tubule lumens without F-actin. This early separation of myosin I␤ and F-actin may result from the rapid degradation of microvillar F-actin by ADF, which is present in these blebs, and the calcium activation of F-actin severing proteins, such as gelsolin (6, 24, 31) . What is clear is that the microvillar F-actin undergoes dramatic alterations within 15 min of ischemia that result in apical enrichment of myosin I␤ and G-actin in this area (31, 35) . A possible scenario to explain what happens to myosin I␤ follows: increased intracellular calcium releases calmodulin from myosin I␤, causing an increase in ATPase activity and membrane binding. This enables the myosin to move quickly up the collapsing microvillar F-actin, where it associates with the membrane as F-actin breaks down. The polarity of F-actin (barbed end apical) is such that myosin I␤ would move to the barbed end. Myosin I␤ could then associate with a select group of acidic phospholipids that collect in the blebs or bind to a receptor protein that has accumulated in the blebs. We are currently examining some of these possibilities by analyzing BBM vesicles from normal and ischemic proximal tubules.
While the precise sequence of these cellular ischemic events is uncertain, it is well established that return of physiological cell and organ function requires reestablishment of the normal cell architecture. This will involve, in part, rebuilding the apical microvilli and retargeting membrane and proteins back to their correct location. We showed in these studies that normal F-actin structure is obtained after 2 h of reperfusion following a 15-min clamp. Surprisingly, myosin I␤ normal staining pattern is not returned to normal. In fact, myosin I␤ is present throughout the cytoplasm in both proximal and distal tubules and often appears in larger punctate structures than in the control tissue. This suggests that either the cellular process(es) in which this motor protein participates has not recovered or it may be actively assisting in the retargeting and/or reorganization of actin cytoskeleton and membrane components. Even after 24 h of reperfusion there are regions of PTC that do not appear normal for myosin I␤. However, at 2 and 24 h of recovery, we have shown that there are only minor changes in both protein and mRNA levels for myosin I␤. This finding suggests that the changes we observe by immunofluorescence are the result of dramatic cytoskeletal and membrane reorganization that occurs after an ischemic insult. Apparently, instead of simply making more of the myosin I␤, the cells have to retarget and reestablish this protein's normal cellular interactions, which our data suggest is not complete even after 24 h of recovery. We believe that interactions of myosin I␤ interactions with membrane phospholipids, F-actin, and possibly membrane proteins undergo significant reorganization during reperfusion that ultimately contributes to the return of functioning kidneys. During this reorganization, a reduced staining pattern for myosin I␤ is observed in the BB. Our results suggest that this is caused by a redistribution of this myosin away from the BB. Analysis of distinct subcellular fractions, i.e., BBM, will help to explain these changes. We are presently examining the recovery time points following the ischemic block to better define the physiological changes that may coincide with the return of myosin I␤. The major conclusion from these studies is that myosin I␤ is present throughout the kidney tubules, its distribution is severely altered by ischemia, and its return follows the apparent structural return of the BB.
